Stratec SE
XETRA:SBS
Stratec SE
Revenue
Stratec SE
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Stratec SE
XETRA:SBS
|
Revenue
€250.5m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
|
|
Carl Zeiss Meditec AG
XETRA:AFX
|
Revenue
€2.1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
|
Revenue
€277.7m
|
CAGR 3-Years
15%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
|
Siemens Healthineers AG
XETRA:SHL
|
Revenue
€22.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Draegerwerk AG & Co KGaA
XETRA:DRW8
|
Revenue
€3.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
|
Sartorius AG
XETRA:SRT
|
Revenue
€3.4B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
13%
|
CAGR 10-Years
14%
|
|
Stratec SE
Glance View
STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. The company is headquartered in Birkenfeld, Baden-Wuerttemberg and currently employs 1,398 full-time employees. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.
See Also
What is Stratec SE's Revenue?
Revenue
250.5m
EUR
Based on the financial report for Sep 30, 2024, Stratec SE's Revenue amounts to 250.5m EUR.
What is Stratec SE's Revenue growth rate?
Revenue CAGR 10Y
6%
Over the last year, the Revenue growth was -2%. The average annual Revenue growth rates for Stratec SE have been -5% over the past three years , 3% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet